亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

HMGB-1 as a Target for Inflammation Controlling

炎症 TLR2型 医学 受体 免疫学 TLR4型 愤怒(情绪) HMGB1 生物 内科学 神经科学
作者
José Augusto Nogueira‐Machado,Caroline Maria Oliveira Volpe
出处
期刊:Recent Patents on Endocrine, Metabolic & Immune Drug Discovery [Bentham Science Publishers]
卷期号:6 (3): 201-209 被引量:94
标识
DOI:10.2174/187221412802481784
摘要

In the present study, we evaluated recent patents that describe products or methods able to down-regulate the pro-inflammatory action of HMGB-1, also called as amphoterin. High Mobility Group Box-1 (HMGB-1) has been implicated in the pathogenesis of inflammatory diseases. HMGB-1 has been proposed to be a crucial mediator in the pathogenesis of many diseases including sepsis, arthritis, cancer, autoimmunity diseases and diabetes. It has been suggested that HMGB-1 itself can signal through RAGEs (receptor for advanced glycation end products) and through the Toll-Like Receptors TLR2 and TLR4. Activation of these receptors results ultimately in the activation of Nuclear Factor-kappaB (NFkappaB), inducing the up-regulation of leukocyte adhesion molecules, production of pro-inflammatory cytokines and angiogenic factors in both hematopoietic and endothelial cells, thereby promoting inflammation. There are several patents proposed for controlling the production, secretion and neutralization of HMGB-1 and consequently the inflammatory process. We have divided the patents in six groups based on mechanism of action. The group 1 is associated with inhibition of HMGB-1 using anti-HMGB-1 antibodies; group 2: inhibition of HMGB-1 releases from the nucleus into the extracellular space; group 3: HMGB-A box as a competitive antagonist of HMGB-1; group 4: blockage of RAGE-HMGB-1 signaling using RAGE antagonists; group 5: blockage of TLR-HMGB-1 signaling using anti-TLR2 antibodies and group 6: other molecules that modulate HMGB-1 activity using e.g. human soluble thrombomodulin. The mechanism of HMGB-1 action, its role and efficiency of each group of patents proposed for controlling inflammation are discussed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被研猫采纳,获得10
1秒前
3秒前
7秒前
8秒前
10秒前
怕孤单的平蝶完成签到 ,获得积分10
12秒前
wzt发布了新的文献求助10
13秒前
14秒前
21秒前
wzt完成签到,获得积分20
23秒前
WQ完成签到,获得积分10
24秒前
Maestro_S的应助被研猫采纳,获得10
24秒前
26秒前
28秒前
depravity完成签到 ,获得积分10
31秒前
31秒前
33秒前
斯文败类的应助被牛马大帝采纳,获得10
34秒前
35秒前
从容的嫣娆完成签到,获得积分10
35秒前
36秒前
zxdxfbf发布了新的文献求助10
39秒前
yjc666发布了新的文献求助10
44秒前
YAN完成签到 ,获得积分10
46秒前
47秒前
47秒前
炙热的无血完成签到,获得积分10
48秒前
慕青的应助被去码头整点薯条采纳,获得30
48秒前
49秒前
打打的应助被研猫采纳,获得10
49秒前
51秒前
null的应助被科研通管家采纳,获得10
54秒前
null的应助被科研通管家采纳,获得10
54秒前
Maestro_S的应助被科研通管家采纳,获得10
54秒前
无花果的应助被科研通管家采纳,获得10
55秒前
爱吃辣条发布了新的文献求助10
56秒前
57秒前
mmhk发布了新的文献求助20
59秒前
暴暴红完成签到 ,获得积分10
59秒前
molihuakai的应助被内啡呔采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158582
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719049
捐赠科研通 7748110
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551881
邀请新用户注册赠送积分活动 2471262